SCM
RLAY icon

Sio Capital Management’s Relay Therapeutics RLAY Stock Holding History

Sio Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-945,839
Closed -$6.7M – 57
2024
Q3 		$6.7M Buy
+945,839
New +$7.07M 2.66% 14
2023
Q2 		– Sell
-230,013
Closed -$3.79M – 55
2023
Q1 		$3.79M Buy
+230,013
New +$4.12M 1.87% 14

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Sio Capital Management's RLAY Position: Q4 2024 in Review

Sio Capital Management sold out of Relay Therapeutics (RLAY) in Q4 2024, closing a stake of 945,839 shares — an estimated $6.7M sold.

Sio Capital Management first reported a position in RLAY in Q1 2023 and held it in 2 quarters. The position peaked at $6.7M in Q3 2024. 199 funds tracked by Wall St. Rank hold RLAY as of Q4 2024.

  • Sio Capital Management reported no remaining Relay Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Sio Capital Management sold 945,839 Relay Therapeutics shares in Q4 2024, an estimated $6.7M.
  • Sio Capital Management first reported a position in Relay Therapeutics in Q1 2023 and held it in 2 quarters.
  • Sio Capital Management's Relay Therapeutics position peaked at $6.7M in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2024.

Based on Sio Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.